Calculating Insulin Dose for Mixtard 30/70
For Mixtard 30/70 (premixed 30% regular/70% NPH insulin), start with 10 units per day or 0.1–0.2 units/kg/day administered twice daily, with approximately two-thirds of the total dose given before breakfast and one-third before dinner. 1, 2
Initial Dosing Strategy
Starting Dose Calculation
- Begin with 10 units per day total OR calculate 0.1–0.2 units/kg/day based on body weight 1, 2
- For twice-daily premixed insulin regimens like Mixtard 30/70, distribute the total daily dose as:
Example: For a 70 kg patient starting at 0.15 units/kg/day:
- Total daily dose = 70 kg × 0.15 = 10.5 units/day
- Morning dose = 7 units
- Evening dose = 3–4 units
When to Use Higher Starting Doses
- If presenting with A1C >10% (>86 mmol/mol) or blood glucose ≥300 mg/dL (≥16.7 mmol/L), consider starting at the higher end of the dosing range (0.2 units/kg/day) 1, 2
- Symptomatic hyperglycemia warrants more aggressive initial dosing 1
Titration Algorithm
Systematic Dose Adjustment
- Increase by 2 units every 3 days until fasting plasma glucose (FPG) goal is achieved without hypoglycemia 1, 2
- Set individualized FPG targets before beginning titration 1, 2
- Adjust each injection (morning and evening) separately based on glucose patterns 1
Hypoglycemia Management
- If hypoglycemia occurs without obvious cause, reduce the corresponding dose by 10–20% 1, 2
- Prescribe glucagon for emergency treatment when initiating insulin therapy 2
- Monitor for both aware and unaware hypoglycemia 1
Critical Considerations for Mixtard 30/70
Advantages of Premixed Formulations
- Mixtard 30/70 eliminates the need for patients to self-mix insulins, improving convenience and reducing dosing errors 3
- Studies demonstrate that patients poorly controlled on various self-mixed ratios can be safely transferred to 70/30 premixed insulin, often dose-for-dose 3
- The fixed ratio provides both prandial coverage (30% regular) and basal coverage (70% NPH) in a single injection 4
Timing and Administration
- Administer before meals (typically breakfast and dinner) 5, 6
- The 30% regular insulin component covers the meal, while the 70% NPH provides intermediate-acting coverage 4
- Never change insulin type, strength, or manufacturer without medical supervision, as this may require dose adjustments 7
Monitoring and Reassessment
Regular Evaluation Points
- Assess adequacy at every visit (every 3–6 months minimum) to avoid therapeutic inertia 1, 2
- Monitor for signs of over-basalization: elevated bedtime-to-morning glucose differential, hypoglycemia, or high glucose variability 1
- Track A1C levels; if A1C remains above goal despite adequate titration, consider intensifying therapy 1
When Mixtard 30/70 May Be Insufficient
- If A1C remains elevated despite optimal twice-daily dosing, consider adding GLP-1 receptor agonists or transitioning to a basal-bolus regimen 1, 2
- Evidence shows that 70/30 insulin algorithms provide superior glycemic control compared to sliding-scale insulin alone 8
- For patients requiring more flexibility, separate basal and prandial insulin components allow independent adjustment 1
Common Pitfalls to Avoid
- Do not use sliding-scale insulin as the primary regimen—scheduled insulin dosing with Mixtard 30/70 is more effective 8
- Avoid changing syringe type or brand without adjusting for potential differences in dead space between manufacturers 7
- Always use U-100 syringes with Mixtard 30/70 to prevent dosing errors; using the wrong syringe concentration can cause serious hypo- or hyperglycemia 7
- Do not delay dose adjustments—titrate systematically every 3 days rather than waiting weeks between changes 1, 2